BELANOFF JOSEPH K 13D and 13G filings for Corcept Therapeutics Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 9:08 pm Purchase |
2024-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
BELANOFF JOSEPH K | 6,822,335 6.300% |
240,417 (+3.65%) |
Filing |
| 2024-02-12 7:51 pm Purchase |
2023-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
BELANOFF JOSEPH K | 6,581,918 6.100% |
500,000 (+8.22%) |
Filing |
| 2023-02-15 4:31 pm Sale |
2022-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
BELANOFF JOSEPH K | 6,081,918 5.500% |
-292,458 (-4.59%) |
Filing |
| 2022-02-11 5:28 pm Purchase |
2021-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
BELANOFF JOSEPH K | 6,374,376 5.800% |
6,412 (+0.10%) |
Filing |
| 2021-02-11 4:31 pm Purchase |
2020-12-31 | 13G | Corcept Therapeutics Incorporated CORT |
BELANOFF JOSEPH K | 6,367,964 5.300% |
990,228 (+18.41%) |
Filing |